Pill halves risk of death in type of lung cancer
Osimertinib is already authorized in dozens of countries for various indications, and has already been given to some 700,000 people, according to a press release from AstraZeneca.
PREMIUM World
American Cancer Society/AFP/Getty Images
By NewVision Reporter
Journalists @NewVision
--------------
A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the